Usefulness of hydralazine to withdraw from dobutamine in severe congestive heart failure

Am J Cardiol. 1991 Oct 15;68(10):1103-6. doi: 10.1016/0002-9149(91)90507-h.
No abstract available

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Dobutamine / administration & dosage*
  • Dobutamine / adverse effects
  • Dobutamine / therapeutic use
  • Female
  • Heart Failure / drug therapy*
  • Heart Failure / physiopathology
  • Hemodynamics / drug effects
  • Humans
  • Hydralazine / administration & dosage*
  • Hydralazine / therapeutic use
  • Male

Substances

  • Hydralazine
  • Dobutamine